Anal Cancer Stage III A research hub

Phase 1b/II Trial of Pembrolizumab Plus IMRT in Stage III/IV Carcinoma of Anus

This study looks at adding a new drug, Pembrolizumab, to standard treatment for advanced anal cancer. Researchers want to see if this combination is safe and how well patients tolerate it, with the aim of improving treatment outcomes.